Latest News

Julie Pilitsis, MD, PhD, MBA  (Credit: The University of Arizona)
Optimizing Parkinson Disease Care With Newly Approved Continuous Infusion Therapy

February 10th 2025

Julie Pilitsis, MD, PhD, MBA, chair of neurosurgery at The University of Arizona Tucson, discussed the impact of a newly approved continuous infusion therapy for Parkinson disease.

Low-Dose Interleukin-2 Reduces Proinflammatory Biomarkers in Phase 2 Study of Alzheimer Disease
Low-Dose Interleukin-2 Reduces Proinflammatory Biomarkers in Phase 2 Study of Alzheimer Disease

February 10th 2025

This Week on NeurologyLive® — February 10, 2024
This Week on NeurologyLive® — February 10, 2024

February 10th 2025

Denali Plans to Submit BLA for Tividenofusp Alfa in Hunter Syndrome Following Positive Phase 1/2 Data
Denali Plans to Submit BLA for Tividenofusp Alfa in Hunter Syndrome Following Positive Phase 1/2 Data

February 9th 2025

NeurologyLive® Brain Games: February 9, 2025
NeurologyLive® Brain Games: February 9, 2025

February 9th 2025

Coverage of the International Stroke Conference 2025

Get direct access to interviews with experts, as well as the latest data and clinical news updates, straight from the conference floor in Los Angeles.

ISC 2025

Conference Coverage

View All
Evolution of Stroke Treatment on Display at ISC 2025: Andrei Alexandrov, MD
Evolution of Stroke Treatment on Display at ISC 2025: Andrei Alexandrov, MD

February 10th 2025

Min Lou MD, PhD
Expanding the Time Window for Intravenous Thrombolysis in Ischemic Stroke: Min Lou MD, PhD

February 10th 2025

 Xiaochuan Huo, MD, PhD
Evaluating Intra-Arterial Tenecteplase for Stroke: Insights From the ANGEL-TNK Trial: Xiaochuan Huo, MD, PhD

February 9th 2025

Endovascular Thrombectomy Provides No Additional Benefit in Medium Vessel Occlusion Stroke, ESCAPE-MeVO Results Show
Endovascular Thrombectomy Provides No Additional Benefit in Medium Vessel Occlusion Stroke, ESCAPE-MeVO Results Show

February 8th 2025

Video Series
Video Interviews
Podcasts

Most Recent

© 2025 MJH Life Sciences

All rights reserved.